A 35,000 s.f., 2-story structural steel “greenfield” cGMP clinical facility containing over 15,000 s.f. of Class 100 to Class 100,000 clean room manufacturing space, plus dedicated administrative offices and laboratories. This strategic facility can produce finished drug forms in parenteral and lyophilized forms and fill both vials and syringes for clinical drug trials, as well as produce other dosage forms such as tablets and capsules. Reverse osmosis water (ROW) is supplied by a remote central utility plant and converted into de-ionized water and water-for-injection (WFI) on-site.